dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 19, 2026

Stock market today: Dow, S&P 500, Nasdaq recover from steep losses as oil's surge eases

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq recover from steep losses as oil's surge eases US stocks cut losses on Thursday as oil prices trimmed gains in afternoon trading on hopes of a deescalation of the conflict in the Middle East…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The oil shock could put downward pressure on growth

    60% confidence
  • Israel would help the US open the Strait of Hormuz and the war would end faster than people think

    60% confidence
  • $200 billion for the war in Iran is a small price to pay

    60% confidence
  • The macroeconomic environment will continue to be challenging with prices at the pump, sticky inflation, and sluggish job market

    60% confidence
  • The Fed's next policy move will likely be a rate hike in the first half of 2027

    60% confidence
  • Inflation had now been over target for five years

    60% confidence
  • Zero employment growth equilibrium is a balance, but not a comfortable balance

    60% confidence
  • Rotation is the lifeblood of a bull market

    60% confidence

Data points we hold from this source

Dow Jones Industrial Average · index close46021.43 points
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq recover from steep losses as oil's surge eases: Source | Via News | fr.via.news